Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

June 27, 2017

America’s biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS), with 52 medicines and vaccines currently in development to help treat and prevent the infection, according to a report released today by PhRMA in partnership with The AIDS Institute.

Read More

New data put medicine costs and spending in context

June 26, 2017

A new era of medicine is when breakthrough science is transforming patient care and enabling us to more effectively treat chronic diseases.

Read More

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

June 26, 2017

Three reasons why repealing Medicare Part D’s noninterference clause is a bad idea.

Read More

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

June 22, 2017

America’s biopharmaceutical companies released a new virtual reality video highlighting innovation and a new era of groundbreaking advancements today to kick off Spotlight Health, the opening segment of the annual 2017 Aspen Ideas Festival.

Read More

Ask About Adherence: Discussion on medication adherence as national priority

June 21, 2017

Discussion on medication adherence as national priority.

Read More

340B Spotlight: ICYMI – AJC looks at how some Georgia hospitals are profiting off 340B

June 20, 2017

The Atlanta Journal-Constitution analyzed data on hospital participation in the 340B program in Georgia and found that some hospitals are raking in profits.

Read More

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

June 19, 2017

A recent study found that imposing VA-style pricing in Part D would have significant, negative long-term implications for patients.

Read More

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

June 14, 2017

Now more than ever, innovative therapies are transforming care.

Read More

As U.S. looks to modernize NAFTA, strong enforcement of existing obligations should be a top priority

June 13, 2017

Yesterday, PhRMA filed comments on negotiating objectives.

Read More

Examining the brain in The New Era of Medicine

June 13, 2017

Biopharmaceutical companies are leading the way in innovation of neurological disorders treatment.

Read More